Literature DB >> 8774919

Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery.

W M Mendenhall1, J T Parsons, A A Mancuso, S P Stringer, N J Cassisi.   

Abstract

BACKGROUND: The purpose of this article is to present the results of radiotherapy with or without neck dissection for squamous cell carcinoma of the supraglottic larynx at the University of Florida and to compare these data with those obtained after conservation surgery.
METHODS: Continuous-course radiotherapy alone or combined with a planned neck dissection was used to treat 209 patients with 211 supraglottic carcinomas between 1964 and 1992; all patients had follow-up for > or = 2 years.
RESULTS: The 5-year rates of local control after radiotherapy were as follows: T1, 100%; T2, 83%; T3, 68%; and T4, 56%. Tumor volume, as calculated on pretreatment computed tomography (CT) scan, and vocal cord mobility influenced the likelihood of local control.
CONCLUSIONS: Based on our data and the literature, early or moderately advanced supraglottic carcinomas may be treated successfully with either supraglottic laryngectomy or radiotherapy. Supraglottic laryngectomy probably produces a higher initial local control rate but, based on anatomic and coexisting medical constraints, is suitable for a smaller subset of patients and has a higher risk of complications compared with radiotherapy.

Entities:  

Mesh:

Year:  1996        PMID: 8774919     DOI: 10.1002/(SICI)1097-0347(199601/02)18:1<24::AID-HED4>3.0.CO;2-0

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  11 in total

1.  Supraglottic laryngectomy: analysis of 267 cases.

Authors:  Maria Agustina Sevilla; Juan Pablo Rodrigo; José Luis Llorente; Rubén Cabanillas; Fernando López; Carlos Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-08       Impact factor: 2.503

2.  Extended and standard supraglottic laryngectomies: a review of 110 patients.

Authors:  Jean-Michel Prades; Pierre-Gilles Simon; Andrei P Timoshenko; Jean-Marc Dumollard; Thierry Schmitt; Christian Martin
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-19       Impact factor: 2.503

3.  Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Chawla; S Kim; L A Loevner; W-T Hwang; G Weinstein; A Chalian; H Quon; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

4.  Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.

Authors:  L P Bron; D Soldati; M-L Monod; C Mégevand; E Brossard; P Monnier; P Pasche
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-08-14       Impact factor: 2.503

Review 5.  Advanced larynx cancer.

Authors:  Scott E Strome; Eric C Weinman
Journal:  Curr Treat Options Oncol       Date:  2002-02

6.  Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer.

Authors:  T Rutkowski; A Wygoda; K Składowski; B Hejduk; R Rutkowski; Z Kołosza; B Maciejewski
Journal:  Strahlenther Onkol       Date:  2013-08-29       Impact factor: 3.621

7.  The Flex robotic system compared to transoral laser microsurgery for the resection of supraglottic carcinomas: first results and preliminary oncologic outcomes.

Authors:  Timon Hussain; Stephan Lang; Pia Haßkamp; Laura Holtmann; Benedikt Höing; Stefan Mattheis
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-01       Impact factor: 2.503

8.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

9.  Late Prevertebral and Spinal Abscess following Chemoradiation for Laryngeal Squamous Cell Carcinoma.

Authors:  Jawad Hindy; Ilan Shelef; Yuval Slovik; Ben-Zion Joshua
Journal:  Case Rep Otolaryngol       Date:  2014-02-19

10.  Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients.

Authors:  Martin Canis; Alexios Martin; Friedrich Ihler; Hendrik A Wolff; Martina Kron; Christoph Matthias; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-10       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.